QTREX Quantum Ltd. (QTEX)
QTEX trades on Nasdaq in Health Care, Medical/Dental Instruments. Numbers below come from the Nasdaq screener and SEC filings, each with its source.
Price, change, market cap, sector and industry: Nasdaq stock screener, as of November 16, 2026. Revenue: SEC 20-F (us-gaap:Revenues), fiscal year ended 2025-12-31, https://www.sec.gov/Archives/edgar/data/1837493/000118518526001072/0001185185-26-001072-index.htm. Net income: SEC 20-F (us-gaap:NetIncomeLoss), fiscal year ended 2025-12-31.
Profile
| Field | Value |
|---|---|
| Ticker | QTEX on Nasdaq |
| Sector | Health Care |
| Industry | Medical/Dental Instruments |
| Country | Israel |
| IPO year | 2021 |
| SEC CIK | 0001837493 |
Financials · 2025
| Line | Value |
|---|---|
| Revenue | $289K |
| Net income | -$13.2M |
| Operating income | -$13.6M |
| Net margin | -4574.4% |
| Operating margin | -4713.8% |
| Revenue growth | No prior-year revenue to compare |
| Cash | $3.2M |
| Total assets | $5.3M |
| P/E (computed) | Net income was not positive |
| P/S (computed) | 222.7× |
Warning signs
| Sign | Finding | Source |
|---|---|---|
| Going concern | States substantial doubt about continuing as a going concern. "Considering the above, the Company's dependency on external funding for its operations raises a substantial doubt about the Company's ability to continue as a going concern." | 20-F 2026-03-26 |
| Cash and burn | $3.2M cash; operating cash flow -$2.5M a quarter. | Report 2025-12-31 |
| Shares outstanding | 35,949,247 (2025-12-31); 24,252,096 a year earlier; 11,338,940 three years earlier. the newest SEC cover-page count is from 2025-12-31; shares issued since then are not in these figures. | Cover page 2025-12-31 |
| Reverse splits, 3 years | None found | None on EDGAR |
| Shelf and offerings, 12 months | 1 S-3/F-3 shelf filings; 4 424B5 takedowns, 4 at the market | Latest 2026-08-21 |
| Exchange deficiency notices, 12 months | None | None on EDGAR |
| Delisting | 25-NSE filed | 25-NSE 2026-07-15 |
| Auditor | Ziv Haft Certified Public Accountants (Isr.), Tel Aviv, Israel | PCAOB Form AP 2026-04-06 |
| Late filings, 12 months | None | None on EDGAR |
| Insider trades, 12 months | Bought $120K, sold $399K on the open market | SEC Forms 3/4/5 data sets 2026-09-30 |
| Market cap check | The listing's market cap implies 55,963,934 shares at the 2026-11-13 price; the latest SEC cover count is 35,949,247 as of 2025-12-31. The SEC count is the older of the two, so the listing's cap is likely the current one; shares were issued since that cover page. | Nasdaq screener and SEC cover page |
From SEC EDGAR submissions, EDGAR full-text search, SEC's Forms 3/4/5 data sets and PCAOB Form AP; computed November 16, 2026. Runway is cash divided by average quarterly operating cash burn. Dilution compares cover-page share counts, corrected for recorded splits.
Annual results
| Fiscal year | Revenue | Net income | Op. cash flow | Cash | Total debt | TTM revenue | Source |
|---|---|---|---|---|---|---|---|
| FY 2025 2025-12-31 | $289K | -$13.2M | -$9.9M | $3.2M | No debt tags | $289K | 20-F 2026-03-26 |
| FY 2024 2024-12-31 | $0 | -$11.1M | -$9.4M | $5.1M | No debt tags | $0 | 20-F 2026-03-26 |
| FY 2023 2023-12-31 | $0 | -$11.3M | -$9.7M | $5.0M | No debt tags | $0 | 20-F 2026-03-26 |
| FY 2022 2022-12-31 | Not filed | -$15.0M | -$9.2M | $6.8M | No debt tags | Needs four quarters | 20-F/A 2025-03-28 |
| FY 2021 2021-12-31 | Not filed | -$17.2M | -$6.7M | $23.9M | No debt tags | Needs four quarters | 20-F 2024-03-25 |
| FY 2020 2020-12-31 | Not filed | $16.9M | -$1.9M | $541K | No debt tags | Needs four quarters | 20-F 2022-03-31 |
| FY 2019 2019-12-31 | Not filed | -$4.6M | -$1.1M | $96K | No debt tags | Needs four quarters | 20-F 2022-03-31 |
From SEC XBRL company facts (annual reports only: 20-F or 40-F). Quarters a filing gives only as year-to-date are computed as differences (Q4 is the fiscal year minus nine months).
Key SEC documents
The SEC filing list did not load in time for this page. It is on SEC EDGAR and in the full dossier.
Price moves
| Window | Return |
|---|---|
| 1 week | +21.4% |
| 1 month | -20.9% |
| 3 months | +25.0% |
| Year to date | +38.9% |
| 1 year | +31.6% |
| From 52-week high | -59.4% |
Source: Yahoo Finance daily closes, last bar 2026-11-13. Computed by MarginsX from daily closes; cap, sector and tier from the Nasdaq screener.
Peers in Medical/Dental Instruments
| Ticker | Company | Price | Day | Market cap |
|---|---|---|---|---|
| LNSR | LENSAR Inc. | $5.29 | +5.80% | $65.0M |
| LUCD | Lucid Diagnostics Inc. | $0.3978 | -11.42% | $82.3M |
| DXR | Daxor Corporation | $8.36 | -0.89% | $48.8M |
| NYXH | Nyxoah SA | $0.8937 | -0.64% | $89.4M |
| ADGM | Adagio Medical Holdings Inc | $1.61 | -16.58% | $44.2M |
| MBOT | Microbot Medical Inc. | $0.6444 | -34.16% | $43.3M |
| MDAI | Spectral AI Inc. | $1.31 | +0.77% | $42.2M |
| SKIN | SkinHealth Systems Inc. | $15.05 | -7.73% | $98.5M |
The full dossier has every filing, three years of financials, private raises and the people who signed them.
Open the full dossier